Press conference on the identification of existing drugs in Japan

Press conference on the identification of existing drugs in Japan

Scene of the press conference. (From right) Kohei Miyazono, Executive Vice President for Research at the University of Tokyo, Makoto Gogami, President of the University of Tokyo, Yuji Yamanashi, Director of the Institute of Medical Science at the University of Tokyo, and Junichiro Inoue, Professor of the Institute of Medical Science at the University of Tokyo. (From right to left: Dr. Kohei Miyazono, Vice President for Research, The University of Tokyo; Dr. Yuji Yamanashi, Director, Institute of Medical Science, The University of Tokyo; and Dr. Junichiro Inoue, Professor, Institute of Medical Science, The University of Tokyo.

  • Product Code
  • ILEA000719293
  • Registered date
  • 2020/3/18 00:00:00
  • Credit
  • THE NIKKAN KOGYO SHIMBUN / Kyodo News Images
  • Media source
  • THE NIKKAN KOGYO SHIMBUN
  • Media size
  • 3000 × 2000 pixel
  • Resolution
  • 350 dpi
  • Deployment size
  • 2.82(MB)*
  • Special instruction
  • **The text may be generated by an automatic translation system**

*File size when opened in Photoshop, etc.

Similar Images & Videos
    KM Biologics begins development of vaccine for novel coronavirus

    KM Biologics begins development of vaccine for novel coronavirus

    KM Biologics (Kita Ward, Kumamoto City) has started to develop a vaccine for a new coronavirus infection. At a press conference held on April 25, President Nagasato said, "Our strength lies in the fact that we have skilled technicians and facilities from our days at the Research Institute for Chemotherapy and Serotherapy (KAKETSUKEN). As a member of the Meiji Group, we will do our utmost to expand this business. The new drug will be developed jointly with the National Institute of Infectious Diseases, the Institute of Medical Science of the University of Tokyo, and the National Institute of Biomedical Innovation, Health and Nutrition. The company will consider using its Kikuchi Research Center in Kikuchi City, Kumamoto Prefecture, and its Koshi Plant in Koshi City, Kumamoto Prefecture, which are capable of producing vaccines for 57 million new influenza cases. (Photo taken on May 25, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
      Japan Education Association estimates the cost of switching to September enrollment

      Japan Education Association estimates the cost of switching to September enrollment

      The Japan Society for Educational Research (JSSER) (Chiyoda Ward, Tokyo; Teruyuki Hirota, President; Professor, Nihon University, College of Letters, Science and Technology) has estimated the cost of the government's plan to switch to September enrollment, which totals more than 6 trillion yen. The government, local governments and households will have to pay more than 1.816 trillion yen to cover the cost of the change, which will lead to the improvement of not only emergency response to the new coronavirus infection but also long-term educational issues.Photo: Teruyuki Hirota (right), president, and Akio Inui, chairman of the special committee to study the issue of September enrollment and the first day of school, at a press conference on May 22, 2020, at the Ministry of Education, Culture, Sports, Science and Technology in Kasumigaseki, Chiyoda-ku, Tokyo.
        Tokyo Governor Koike inspects a medical facility responding to the new corona.

        Tokyo Governor Koike inspects a medical facility responding to the new corona.

        Tokyo Governor Yuriko Koike visited the Ikebukuro Public Health Center, Komagome Hospital, and other institutions and organizations that are responding to the new coronavirus (COVID-19). The photo shows Tokyo Governor Koike (far right) being welcomed by officials upon his arrival at Komagome Hospital. (May 14, 2020, Bunkyo Ward, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
          Tokyo Governor Koike inspects a medical facility responding to the new corona.

          Tokyo Governor Koike inspects a medical facility responding to the new corona.

          Tokyo Governor Yuriko Koike visited the Ikebukuro Public Health Center, Komagome Hospital, and other institutions and organizations that are responding to the new coronavirus (COVID-19). The photo shows Governor Koike (center) repeatedly thanking the officials after the visit to Komagome Hospital. (May 14, 2020, Bunkyo Ward, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
            Tokyo Governor Koike inspects a medical facility responding to the new corona.

            Tokyo Governor Koike inspects a medical facility responding to the new corona.

            Tokyo Governor Yuriko Koike visited the Ikebukuro Public Health Center, Komagome Hospital, and other institutions and organizations that are responding to the new coronavirus (COVID-19). The photo shows a question-and-answer session at Komagome Hospital. (May 14, 2020, Bunkyo Ward, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
              Press conference on the identification of existing drugs in Japan

              Press conference on the identification of existing drugs in Japan

              The photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo taking off his mask for explanation. (March 18, 2020, Yasuda Auditorium, University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                Press conference on the identification of existing drugs in Japan

                Press conference on the identification of existing drugs in Japan

                Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                  Press conference on the identification of existing drugs in Japan

                  Press conference on the identification of existing drugs in Japan

                  Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                    Press conference on the identification of existing drugs in Japan

                    Press conference on the identification of existing drugs in Japan

                    Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                      Press conference on the identification of existing drugs in Japan

                      Press conference on the identification of existing drugs in Japan

                      Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)